Neurocrine Biosciences Inc (NASDAQ:NBIX)

93.37
Delayed Data
As of Apr 09
 +0.67 / +0.73%
Today’s Change
86.02
Today|||52-Week Range
136.26
-2.59%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close92.69
Today’s open93.01
Day’s range91.70 - 94.02
Volume15,725
Average volume (3 months)1,109,144
Market cap$9.2B
Data as of 3:59pm ET, 04/09/2021

Growth & Valuation

Earnings growth (last year)+983.16%
Earnings growth (this year)-22.03%
Earnings growth (next 5 years)+18.10%
Revenue growth (last year)+32.71%
P/E ratio22.4
Price/Sales8.96
Price/Book8.11

Competitors

 Today’s
change
Today’s
% change
CRSPCRISPR Therapeutics ...-4.82-4.00%
XLRNAcceleron Pharma Inc-2.30-1.78%
FATEFate Therapeutics In...-1.18-1.49%
IBRXImmunitybio Inc-1.84-9.84%
Data as of 4:29pm ET, 04/09/2021

Financials

Next reporting dateMay 3, 2021
EPS forecast (this quarter)$0.55
Annual revenue (last year)$1.0B
Annual profit (last year)$407.3M
Net profit margin38.94%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts